MARKET

VVOS

VVOS

Vivos Therapeutics, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.00
+0.17
+2.49%
Opening 11:16 01/20 EST
OPEN
6.80
PREV CLOSE
6.83
HIGH
7.18
LOW
6.75
VOLUME
30.09K
TURNOVER
--
52 WEEK HIGH
14.41
52 WEEK LOW
5.64
MARKET CAP
122.50M
P/E (TTM)
-12.3740
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Vivos Therapeutics (VVOS) Receives a Buy from Craig-Hallum
In a report released yesterday, Alexander Nowak from Craig-Hallum initiated coverage with a Buy rating on Vivos Therapeutics (VVOS) and a price target of
SmarterAnalyst · 01/12 08:35
DJ Vivos Therapeutics Price Target Announced at $12.00/Share by Craig-Hallum
Dow Jones · 01/11 17:36
DJ Vivos Therapeutics Initiated at Buy by Craig-Hallum
Dow Jones · 01/11 17:36
Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea
Vivos Therapeutics, Inc. ("Vivos") (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea, announced today its c...
GlobeNewswire · 01/06 13:00
Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea
GlobeNewswire · 01/06 13:00
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 4)
Benzinga · 01/05 13:38
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 29)
Benzinga · 12/30/2020 13:08
Insider Buys Vivos Therapeutics Shares
 
Benzinga · 12/28/2020 16:26
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VVOS. Analyze the recent business situations of Vivos Therapeutics, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VVOS stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About VVOS
Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a differentiated technology offering a clinically effective non-surgical, non-invasive and non-pharmaceutical for patients with sleep disordered breathing (SDB), including obstructive sleep apnea (OSA). It is engaged in the designing and selling of oral devices that assist with sleep and breathing disorders and hosting training seminars for medical and dental professionals on sleep and breathing disorders. The Company owns and operates three locations where Vivos systems are measured and fitted. The Company licenses its intellectual property to third-party manufacturers which fabricate appliance devices for orders requested by healthcare professionals, at a specified price per appliance.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Vivos Therapeutics Inc stock information, including NASDAQ:VVOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VVOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VVOS stock methods without spending real money on the virtual paper trading platform.